Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (6131)	1/12/1999 4:01:00 PM
From: Craig Markell	Read Replies (1) \| Respond to of 7041

Like I said, look for SGP to buyout Zonagen later this year after FDA approval. The UK is only the first EU country expected to approve Vasomax. Amazing how these analysts have fallen for the Vasomax "fraud". Could it be that the shorts on this board are wrong.... Noooooo.

To: Dauntless who wrote (6131)	1/12/1999 4:12:00 PM
From: Ron Sigourney	Respond to of 7041

Dauntless, Thanks, for the post. I also saw it on Yahoo. $4/share (year 2002) @ 20 PE does make this an $80 stock. But be careful 2002 is still 3 years away, and alot can happen. Still IMHO ZONA would allow a buyout if the price were right. Time will tell. Happy investing to you all.